IBDEI0PN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11527,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,11527,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,11527,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,11528,0)
 ;;=E10.65^^46^558^6
 ;;^UTILITY(U,$J,358.3,11528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11528,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,11528,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,11528,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,11529,0)
 ;;=E11.21^^46^558^9
 ;;^UTILITY(U,$J,358.3,11529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11529,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,11529,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,11529,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,11530,0)
 ;;=E10.29^^46^558^3
 ;;^UTILITY(U,$J,358.3,11530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11530,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,11530,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,11530,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,11531,0)
 ;;=E10.21^^46^558^4
 ;;^UTILITY(U,$J,358.3,11531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11531,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,11531,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,11531,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,11532,0)
 ;;=E11.40^^46^558^10
 ;;^UTILITY(U,$J,358.3,11532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11532,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,11532,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,11532,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,11533,0)
 ;;=E10.40^^46^558^5
 ;;^UTILITY(U,$J,358.3,11533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11533,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,11533,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,11533,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,11534,0)
 ;;=E10.22^^46^558^2
 ;;^UTILITY(U,$J,358.3,11534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11534,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,11534,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,11534,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,11535,0)
 ;;=E10.9^^46^558^7
 ;;^UTILITY(U,$J,358.3,11535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11535,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,11535,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,11535,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,11536,0)
 ;;=E11.22^^46^558^8
 ;;^UTILITY(U,$J,358.3,11536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11536,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,11536,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,11536,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,11537,0)
 ;;=E11.9^^46^558^12
 ;;^UTILITY(U,$J,358.3,11537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11537,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,11537,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,11537,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,11538,0)
 ;;=E13.22^^46^558^1
 ;;^UTILITY(U,$J,358.3,11538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11538,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,11538,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,11538,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,11539,0)
 ;;=E83.30^^46^559^26
 ;;^UTILITY(U,$J,358.3,11539,1,0)
 ;;=^358.31IA^4^2
